Margit Mahlapuu
chairman
management
Promore Pharma
Sweden
Biography
Born: 1972. Margit has over 15 years of experience in pharmaceutical research and development. Most recently, she served as CEO of the Sweden-based biotech company PharmaSurgics. Prior to that, she had assignments at companies such as AstraZeneca, Arexis, and Swedish Orphan Biovitrum. Margit holds an associate professorship in molecular medicine at Sahlgrenska Academy, Sweden. She has a Ph.D. in molecular and cellular biology from the University from Gothenburg. Margit joined the company in 2007 and has since then been responsible for regulatory affairs strategy and clinical development. Other Assignments: Margit is a director of the board in Sixera AB and she is the principal in two fully owned companies; Arexela AB, which is a consulting company, and ScandiCure AB, which is an intellectual property holding company. Share Holding in Promore Pharma: No current holding.
Research Interest
molecular and cellular biology
